Clinical Trial: LBBP + CSP Versus LBBP Alone for Cardiac Resynchronization Therapy

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664189) titled 'LBBP + CSP Versus LBBP Alone for Cardiac Resynchronization Therapy' on May 26.

Brief Summary: The purpose of this pilot clinical trial is to evaluate whether a novel cardiac resynchronization strategy, called LOT-CRT, is more effective than standard physiological pacing alone (LBBAP) in patients with heart failure.

This is a randomized, single-center, crossover pilot study involving 10 patients. All participants will receive a specialized pacemaker (CRT-P) with leads implanted in two specific areas: the Left Bundle Branch Area (LBBAP) and the Coronary Sinus (CS).

Because of the crossover design, each patient will serve as their ow...